Integra LifeSciences Holdings (IART)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 111,526 143,319 181,775 229,138 238,920 229,303 220,693 212,680 197,230 191,652 192,755 154,981 151,370 134,805 56,676 88,555 93,760 91,788 136,052 117,727
Total assets US$ in thousands 3,781,990 3,739,370 3,777,600 3,742,400 3,889,760 3,807,010 3,752,860 3,672,000 3,782,380 3,774,460 3,712,790 3,741,550 3,615,140 3,453,520 3,391,760 3,447,560 3,303,240 3,346,580 3,290,410 3,205,710
Operating ROA 2.95% 3.83% 4.81% 6.12% 6.14% 6.02% 5.88% 5.79% 5.21% 5.08% 5.19% 4.14% 4.19% 3.90% 1.67% 2.57% 2.84% 2.74% 4.13% 3.67%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $111,526K ÷ $3,781,990K
= 2.95%

Integra Lifesciences Holdings Corp's operating return on assets (operating ROA) has been fluctuating over the past eight quarters, as evidenced by the data provided. The trend shows a gradual decline in operating ROA from 6.14% in Q4 2022 to 2.95% in Q4 2023.

The operating ROA peaked at 6.14% in Q4 2022 and has since experienced a downward trend, indicating potential challenges or reduced efficiency in generating operating income relative to total assets. While operating ROA increased in Q3 2023 and Q2 2023, it still remained below the peak level recorded in Q4 2022.

This downward trend in operating ROA may suggest a need for the company to focus on effectively managing its operations to improve profitability in relation to its asset base. Further analysis of the company's cost structure, operational efficiency, and asset utilization could provide insights into the factors driving the fluctuations in operating ROA over the quarters. Monitoring and addressing these factors are important for sustaining and enhancing the company's financial performance in the long term.


Peer comparison

Dec 31, 2023